VIENNA, Austria — Compared with subcutaneous interferon β-1a (IFNB-1a; Rebif/EMD Serono/Pfizer), treatment with alemtuzumab (Lemtrada, Genzyme/Sanofi) improved visual outcomes in treatment-naive ...
Blindness profoundly affects people's lives. Around the world, several laboratories, including the Biomedical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback